The content on this site is intended for healthcare professionals only
Conferences
ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
ASCO GI 2022
20 - 22 Jan 2022
Moscone West, San Francisco, United States of America
Tumour agnostic treatments in GI cancer
Dr Nicola Normanno and Dr Katja Schmitz
1 Feb 2022
Durvalumab plus chemotherapy significantly improved OS in advanced biliary tract...
Dr Do-Youn Oh - Seoul National University College of Medicine, Seoul, South Kore...
27 Jan 2022
Early treatment discontinuation and early oxaliplatin discontinuation for stage ...
Dr Claire Gallois - Hôpitaux Universitaires Paris-Ouest, Paris, France
27 Jan 2022
HIMALAYA: Study of tremelimumab and durvalumab as first-line therapy in patients...
Dr Ghassan K. Abou-Alfa - Memorial Sloan Kettering Cancer Center, New York, USA
27 Jan 2022
Comparing two chemo regimen and chemoradiotherapy regimen as neoadjuvant treatme...
Dr Ken Kato - National Cancer Center Hospital, Tokyo, Japan
25 Jan 2022
Nivo + chemo vs chemo as first-line treatment for advanced GC/GEJC/EAC
Dr Kohei Shitara - National Cancer Center Hospital East, Kashiwa, Japan
20 Jan 2022